Evaluation of the Efficacy and Safety of Polatuzumab Vedotin Combined With Rituximab, Gemcitabine, and Oxaliplatin (Pola-R-GemOx) as Salvage Therapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Patients Ineligible for Autologous Transplantation

Abroad (travel likely)RecruitingPHASE2

Conditions

Diffuse Large B-Cell Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Fudan University Shanghai Cancer Center, Shanghai, Shanghai Municipality, China
Contact: Study coordinator (Wenhao Zhang, M.D) · ZWHL98@foxmail.com · 021-64175590

Study leads

Wenhao Zhang, M.D
Principal Investigator
Fudan University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Nemtabrutinib and Pembrolizumab for the Treatment of Richter Transformation, Diffuse Large B-cell Lymphoma Subtype

Richter Syndrome · Diffuse Large B-Cell Lymphoma · Chronic Lymphocytic Leukemia

Abroad (travel likely)RecruitingPHASE2

Buffalo, United States

Golcadomide Post-CAR T-cell in R/R Aggressive Large B-cell Lymphoma Patients With High Risk of Relapse

Diffuse Large B-cell Lymphoma Refractory · Refractory Primary Mediastinal Large B-Cell Lymphoma · Refractory Transformed B-cell Non-Hodgkin Lymphoma

Abroad (travel likely)RecruitingPHASE2

Créteil, France · Dijon, France

R-CDOP Combined With Intrathecal Methotrexate for DLBCL Patients With High-risk of CNS Relapse

Diffuse Large B-cell Lymphoma

Abroad (travel likely)RecruitingPHASE2

Shanghai, China · Ürümqi, China

Study of Safety and Efficacy of TC011 in the Relapsed/Refractory Large B Cell Non-Hodgkin Lymphoma Patients

Relapsed Large B-cell Lymphoma · Refractory Large B-cell Lymphoma · Diffuse Large B-cell Lymphoma (DLBCL)

Abroad (travel likely)RecruitingPHASE1, PHASE2

Seoul, South Korea